Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease

Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats

(2013) Melissa M. Conti et al.   NEUROPHARMACOLOGY

Serotonin transporter inhibition attenuatesl-DOPA-induced dyskinesia without compromisingl-DOPA efficacy in hemi-parkinsonian rats

(2012) Christopher Bishop et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia

(2011) Nina Nevalainen et al.   JOURNAL OF NEUROCHEMISTRY

The serotonergic system in Parkinson's disease

(2011) Philippe Huot et al.   PROGRESS IN NEUROBIOLOGY

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia

(2010) Daniella Rylander et al.   ANNALS OF NEUROLOGY

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats

(2009) Karen L. Eskow et al.   SYNAPSE